Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create new drugs in the areas of cancer, immunology and infection. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.
Appointment of Chairman
20 April 2017
Redx Pharma announces that it has appointed Mr Iain Ross as Chairman of its Board of Directors and as a Non-Executive Director of the Company, effective from 1 May 2017.
Mr Ross has over 35 years’ of experience having held Senior Board and Management positions at multiple public and private companies in the life sciences sector.
Currently Mr Ross serves as Non-Executive Chairman of AIM quoted e-Therapeutics plc and Biomer Technology Ltd alongside his Non-Executive Directorships at London listed Premier Veterinary Group plc, ASX quoted Anatara LifeSciences Ltd and Novogen Ltd, and as a Director of Aldershot Town Football Club.
31 Mar 2017
US$1mln grant is ‘testament to the great science’ ongoing at Redx, CSO says
21 Mar 2017
Redx Pharma to refocus on key assets
10 Feb 2017
Cash influx will help Redx develop promising pre-clinical drug candidates